| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1096-9071(199612)50:4<283::AID-JMV1>3.0.CO;2-4 |
| P698 | PubMed publication ID | 8950683 |
| P2093 | author name string | Zuckerman JN | |
| P2860 | cites work | The immune response to hepatitis B vaccine in humans: inheritance patterns in families | Q36230907 |
| Immunization against hepatitis B--what can we expect? Results of a survey of antibody response to immunization in persons 'at risk' of occupational exposure to hepatitis B | Q36504906 | ||
| Immune response to hepatitis B virus proteins: relevance of the murine model | Q37102986 | ||
| Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. | Q37510933 | ||
| Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region | Q37557540 | ||
| Viral persistence | Q38602842 | ||
| Hepatitis B vaccine: immunogenicity and follow-up including two year booster doses in high-risk health care personnel in a London teaching hospital | Q41341859 | ||
| Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. | Q41381718 | ||
| Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen | Q41616784 | ||
| Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of Efficacy | Q42244325 | ||
| Hepatitis B vaccination: protection for how long and against what? | Q43152234 | ||
| Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines | Q43609992 | ||
| Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination | Q43921238 | ||
| Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity | Q43990300 | ||
| A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report | Q44266138 | ||
| Hepatitis B vaccine: responder status and timing of additional booster doses | Q44804083 | ||
| Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). | Q44822458 | ||
| Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response | Q44827092 | ||
| Antibody response to pre-S2 and hepatitis B virus induced liver damage | Q45839782 | ||
| Is nonresponsiveness to hepatitis B vaccine due to latent hepatitis B virus infection? | Q45868354 | ||
| Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing | Q57208602 | ||
| Use of immunomodulators (thymopentine) in hepatitis B vaccine in elderly patients undergoing chronic hemodialysis | Q67546566 | ||
| Immune response to hepatitis B revaccination | Q68349734 | ||
| Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine | Q68415845 | ||
| HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccination | Q69106699 | ||
| Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination | Q69366949 | ||
| Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men | Q69997141 | ||
| Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings | Q70008904 | ||
| Acquired forms of immunosuppression | Q70214272 | ||
| The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men | Q71617412 | ||
| Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines | Q71679836 | ||
| Randomized comparative trial of interferon-alpha versus placebo in hepatitis B vaccine non-responders and hyporesponders | Q72042135 | ||
| Hepatitis B vaccine boosting: the debate continues | Q72172533 | ||
| Hepatitis B vaccination follow-up | Q72336123 | ||
| Hepatitis B vaccination: how long does protection last? | Q72586604 | ||
| Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine | Q72692139 | ||
| Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy | Q72820566 | ||
| Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations | Q72822465 | ||
| Immunologic Prevention of Human Hepatitis | Q72823459 | ||
| Genetic prediction of nonresponse to hepatitis B vaccine | Q93518433 | ||
| P433 | issue | 4 | |
| P921 | main subject | Hepatitis B vaccine | Q117749 |
| P304 | page(s) | 283-288 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | Journal of Medical Virology | Q15716684 |
| P1476 | title | Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production | |
| P478 | volume | 50 |
| Q36787928 | A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection |
| Q42252783 | A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations |
| Q73871011 | A multi-center controlled study of rapid hepatitis B vaccination using a novel triple antigen recombinant vaccine |
| Q74252431 | Analysis of the relationship between immunogenicity and immunity for viral subunit vaccines |
| Q59349519 | Association of IL-10 and IL-10RA single nucleotide polymorphisms with the responsiveness to HBV vaccination in Chinese infants of HBsAg(+)/HBeAg(-) mothers: a nested case-control study |
| Q39827413 | B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin. |
| Q40836583 | Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines |
| Q74089616 | Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination |
| Q51582139 | Decrease in CD4+ T lymphocyte proliferation responses and enhanced CD150 cell expression in health care workers non-responsive to HBV vaccine. |
| Q38261395 | Ex vivo assessment of cellular immune function - applications in patient care and clinical studies |
| Q33901610 | Genetic determinants of immune-response to a polysaccharide vaccine for typhoid. |
| Q23910391 | Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations |
| Q37102102 | Genomic correlates of variability in immune response to an oral cholera vaccine |
| Q81405829 | Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination |
| Q74092600 | Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination |
| Q39729787 | Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan |
| Q34550746 | Hepatitis B: epidemiological, immunological, and serological considerations emphasizing mutation |
| Q40398915 | Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response. |
| Q36404398 | Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination |
| Q44447203 | Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium |
| Q23910390 | Influence of cytokine gene variations on immunization to childhood vaccines |
| Q44525165 | Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003-2006. |
| Q40399420 | Polymorphisms in IRG1 gene associated with immune responses to hepatitis B vaccination in a Chinese Han population and function to restrain the HBV life cycle |
| Q35671639 | Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study |
| Q47907168 | Psychological but not vasomotor symptoms are associated with temperament and character traits |
| Q73816635 | Response to hepatitis-B vaccination in healthy homosexual individuals: retrospective case control study |
| Q37323832 | Seroprevalence of hepatitis B virus among health care workers in Korea |
| Q39463463 | Seroprevalence of hepatitis B virus infection and seroconvertion to anti-HBsAg in laboratory staff in Goiânia, Goiás |
| Q36830379 | Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe? |
| Q90425486 | Study of the association of seventeen single nucleotide polymorphisms and their haplotypes in the TNF-α, IL-2, IL-4 and IL-10 genes with the antibody response to inactivated Japanese encephalitis vaccine |
| Q37556764 | T cell epitope: friend or foe? Immunogenicity of biologics in context |
| Q78424586 | The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population |
| Q45855058 | Therapy for chronic hepatitis B and C infection in haemophilia |
Search more.